Vor Biopharma (VOR) Preferred Dividend Payments (2020 - 2021)
Vor Biopharma (VOR) posted quarterly Preferred Dividend Payments of $1.2 million for Q1 2021, up 71.75% year-over-year from $715000.0 in Q1 2020, and down 43.41% quarter-over-quarter from $2.2 million in Q4 2020.
Vor Biopharma (VOR) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Vor Biopharma (VOR) has reported Preferred Dividend Payments for 2 consecutive years, with $1.2 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Preferred Dividend Payments rose 71.75% year-over-year to $1.2 million; the TTM figure through Dec 2021 stood at $1.2 million (down 79.27% YoY), while the FY2021 annual figure was $1.2 million, down 79.27% from the prior year.
- Preferred Dividend Payments declined to $1.2 million in Q1 2021 per VOR's latest filing, from $2.2 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.2 million in Q3 2020 and bottomed at $715000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.23 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 855,000.00 |
| Mar 31, 2020 | 715,000.00 |